Your browser doesn't support javascript.
loading
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival.
van der Voort, Anna; Liefaard, Marte C; van Ramshorst, Mette S; van Werkhoven, Erik; Sanders, Joyce; Wesseling, Jelle; Scholten, Astrid; Vrancken Peeters, Marie Jeanne T F D; de Munck, Linda; Siesling, Sabine; Sonke, Gabe S.
Affiliation
  • van der Voort A; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Liefaard MC; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Werkhoven E; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Sanders J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Wesseling J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Scholten A; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Vrancken Peeters MJTFD; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; University of Amsterdam, the Netherlands.
  • de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
  • Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands; Department of Health Technology and Services Research (HTSR), University of Twente, Enschede, the Netherlands.
  • Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; University of Amsterdam, the Netherlands. Electronic address: g.sonke@nki.nl.
Breast ; 65: 110-115, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35921798
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Netherlands